Dr. William N. Harwin, MD

Dr. Harwin practices at Florida Cancer Specialists P L in Tampa, Florida.

Dr. Harwin's NPI, 1164413589, was assigned on November 3, 2005. Dr. Harwin graduated from Baylor College Of Medicine in 1978. Dr. Harwin's Florida license number on file is ME35430.

Dr. Harwin's primary practice is Florida Cancer Specialists P L, at 3238 Cove Bend Dr, Tampa, FL 33613-2752. The practice phone is (813) 632-7547. The NPI Registry lists Dr. Harwin's practice address as 1708 Cape Coral W Pkwy, Cape Coral, FL 33914.

Dr. Harwin's primary practice is Florida Cancer Specialists P L in Tampa, Florida. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Harwin to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harwin practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Harwin's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Harwin is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Harwin's licenses on file in 2 states: Florida and Utah.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Harwin treats.

CMS data shows 85,686 Medicare services from Dr. Harwin across 45 procedure codes in 2023. Medicare paid $1,483,454 for them. Every service was in an office.

Across all payers, Dmand AI patient panel data puts Dr. Harwin's median patient age at 70, with 78% women.

In 2024, Dr. Harwin wrote 52 Medicare Part D claims for 38 patients. 87% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $400 in total drug cost. In 2023, CMS named 833 claims across 27 drugs.

Dmand AI links 9 papers to Dr. Harwin, published from 2015 to 2017. 2015 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Doxorubicin and Paclitaxel. Dr. Harwin has published most often in Breast Cancer Res Treat. Dr. Harwin's most frequent co-authors are Linda Diana Bosserman, FACP, MD, John D. Hainsworth, MD and Daniel E. Dosoretz, MD.

Dmand AI links Dr. Harwin to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Lymphoma, Large B-Cell, Diffuse and Rectal Diseases.

CMS Open Payments shows 344 general payments to Dr. Harwin from 57 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 48% of the total. Daiichi Sankyo Inc. paid the most, $25,581.

Dmand AI lists 5 awards for Dr. Harwin, most recently CMS Stage 1 EHR in 2014.

Dr. Harwin graduated from Baylor College Of Medicine in 1978. Dr. Harwin is a member of ASCO.

Dr. Harwin is in network with 2 carriers, including Cigna and GA State Medicaid. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.